Publications:
The Pink Book: Errata, Updates & Clarifications
Epidemiology
and Prevention of Vaccine Preventable
Diseases
UPDATED
11th Edition (May 2009)
Latest Entry: 9/15/09
UPDATE
Poliomyelitis Chapter
The Polio chapter states, on page 238, that "the minimum interval between all doses of IPV is 4 weeks, and the minimum age for the fourth dose is 18 weeks" and that "If all four IPV doses are administered after 6 weeks of age and are all separated by at least 4 weeks, a fifth dose is not needed, even if the fourth dose was administered before 4 years of age . . ."
These statements are superseded by updated ACIP recommendations (MMWR, Vol. 58, No. 30, August 7, 2009), stating that the final dose in the IPV series should be administered at 4 years of age or older, regardless of the number of previous doses, and that the minimum interval between dose 3 and dose 4 has been extended from 4 weeks to 6 months.
The third slide on page 237 should also reflect these changes. The "4-6 years" minimum interval should be 6 months (not 4 weeks), and the footnote "the fourth dose of IPV may be given as early as 18 weeks of age" should say instead "the final dose of IPV should be given on or after the 4th birthday." (9/15/09)
UPDATE
Appendix A
The "Recommended Minimum Ages and Intervals" table (page A8) should reflect updated recommendations for IPV (see above). The "Minimum age for this dose" for IPV-4 should be 4 years (not 18 weeks) and the "Minimum interval to next dose" for IPV-3 should be 6 months, not 4 weeks. These changes have been made on the online version of this table. (9/15/09)
UPDATES
Appendix B
Hiberix, GSK's recently licensed Hib vaccine, has been added to the online versions of the U.S. Vaccines table and the Latex in Vaccine Packaging table. (8/28/09)
UPDATES
Appendix B
Two additional updates have been made to the online version of the U.S. Vaccines table (http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/us-vaccines.pdf). Daptacel is now licensed for the 5th DTaP dose, so the sentence "Not licensed for 5th dose" has been removed from the last column (page B-1). FluMist is now licensed for children as young as 2 years of age. The sentence in the last column now reads "Age range 2-49 years." (page B-3). (8/28/09)
ERRATUM
Appendix B
The Latex in Vaccine Packaging table (page B-18) contains outdated information for Prevnar. This table has been updated online (http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/latex-table.pdf).(6/5/09)
ERRATUM
Appendix C
The Storage and Handling booklet contains a typo on page C-15 (PPSV). Under "Shelf Life After Opening" the phrase "Multidose Syringes" should read "Multidose Vials." This has been corrected online (http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/C/storage-handling.pdf). (6/5/09)
Return to the Pink Book main page
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
Content last reviewed on June 5, 2009
Content Source: National Center for Immunization and Respiratory Diseases